Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
9
×
biotech
life sciences
new york blog main
boston blog main
boston top stories
national
precision medicine
new york top stories
san diego blog main
san diego top stories
boston
cancer
genomics
san diego
san francisco blog main
blackstone group
bristol-myers squibb
clinical trials
david goldstein
depression
detroit blog main
detroit top stories
epilepsy
essential tremor
exome
immuno-oncology
kiran reddy
life science
major depressive disorder
oncology
perimenopausal depression
praxis precision medicines
raleigh-durham blog main
san francisco top stories
startups
steven petrou
wisconsin blog main
xconsd
What
precision
9
×
medicine
genomics
new
san
biotech
conference
diego’s
drugs
life
medicines
oncology
podcast
praxis
research
sciences
series
week
xcelerating
aims
ambitious
ann
annual
arbor
backed
based
benefiting
biomedical
biotechs
bird
boston
breakthroughs
breast
building
cancer
cancer's
cause
central
ceo
chunk
Language
unset
Current search:
precision
×
" national top stories "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round